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ABSTRACT
Fibromyalgia (FM) is a chronic pain condition that is second only to
osteoarthritis. Fibromyalgia greatly impacts the quality of life with its many symptoms
requiring a multidisciplinary approach to treatment. The recommendation is that patients
with fibromyalgia are treated in primary care as are other chronic diagnoses such as
hypertension and diabetes with referrals to other disciplines as needed. However, some
primary care providers may not recognize fibromyalgia as a valid diagnosis, have
received inadequate formal training in fibromyalgia, and may have limited awareness of
diagnostic criteria.
According to the research, there are as many as 3 out of 4 people with
fibromyalgia that go undiagnosed in any primary care practice. Providers in primary care
are usually the first to evaluate patients, therefore, providers in primary care need to
recognize fibromyalgia symptoms, start initial treatment, and refer for further
consultation if required. Fibromyalgia (FM) symptoms can be debilitating, prolonged,
and negatively affect the patient's lives, environment, and family and friends. Decreases
in physical ability, intellectual activity, emotional condition are some of the
consequences of FM. Professional careers, personal relationships, and mental health may
require, requiring several strategic interventions by several disciplines in healthcare
settings. Making the need for the use of a screening tool that includes the diagnostic
criteria essential. Fibromyalgia occurs frequently in the general adult population
worldwide, no treatment that cures, and limited knowledge of the cause has produced
patient dissatisfaction with the time it takes to diagnose, formulate a treatment plan, and
as a result, has led to the development of this DNP project. Given fibromyalgia
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symptomatology, absenteeism from work with a decreased quality of life, and the
inability it often produces, it is essential that providers, especially in primary care, be
knowledgeable regarding the diagnostic criteria for FM using a screening tool. Using the
American College of Rheumatology (ACR) screening tool will assist in early diagnosis
and treatment. The screening tool consists of symptom severity (SS) and widespread pain
index (WPI), with no curative diagnostic screening which aids in early diagnosis and
treatment of fibromyalgia.
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CHAPTER I - INTRODUCTION
Fibromyalgia (FM) is a chronic, complex disease characterized by diffuse chronic
mild, moderate, and severe widespread pain (SWP) and chronic fatigue syndrome (CFS),
often reported as the worst symptom associated with fibromyalgia (Baron et al., 2014).
Other distressing symptoms include sleep disturbances, gastrointestinal symptoms,
memory problems, headaches, tingling, stiffness, numbness, decreased libido, bowel,
bladder difficulties, anxiety, and depression, an overwhelming length of time. Many
debilitating symptoms make it very difficult to diagnose and treat (Baron et al., 2014).
The American College of Rheumatology (2021) estimates that about 2% of the world's
population meets the 2010 modified diagnostic criteria for fibromyalgia syndrome.
Those patients diagnosed with FM reported that they are never free from
symptoms. Wierwille (2011) noticed that the diagnostic goal is to promote treatment
early and improve life quality by reducing symptoms. Working with FM patients can
become disheartening for providers because of the difficulty in diagnosing and finding an
effective and proven treatment that works for their patients. When a person has FM
symptoms, many patients have been evaluated by several providers, including specialists
and a long list of diagnostic tests, without a definitive diagnosis (Arnold et al., 2011). In
most instances, the patient first reports to their provider in primary care without a
definitive diagnosis. Therefore, it is essential to educate providers in primary care about
the diagnostic criteria provided in a screening tool recommended by ACR (Wolfe et al.,
2010).
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Background
The most common chronic pain condition is seen in primary care, and the least
diagnosed is FM. There are at least twenty undiagnosed FM patients in the average
primary care clinic (Wolfe et al., 2010). The American College Rheumatology's (ACR)
(2021) recommended tool for diagnosing FM, using the ACR diagnostic criteria
screening tools, is the widespread pain index (WPI) and severity of symptoms (SS). This
DNP project aimed to educate providers in primary care on the diagnostic criteria tool
needed for a definitive diagnosis.
Significance
FM is a controversial condition where this population has seen numerous
providers when a definitive diagnosis has been provided. Some of these providers are
rheumatologists, general practitioners, pain specialists, and mental healthcare specialists.
The FM population may complain of SWP, CFS, depression, intestinal symptoms,
headaches, and many other complaints. We now know a complex presentation of
symptoms as FM remains challenging to providers due to the multifaceted list of
symptoms.
The most common chronic pain condition is seen in primary care is FM and is the
least diagnosed. There are at least twenty undiagnosed FM patients in a primary care
clinic (Wolfe et al., 2010). The American College Rheumatology's (ACR) (2021)
recommended tool for diagnosing FM, using the ACR diagnostic criteria screening tools,
is the widespread pain index (WPI) and SS. This DNP project aimed to educate providers
in primary care on the diagnostic criteria tool needed for a definitive diagnosis. This DNP
project aimed to educate providers in primary care on the diagnostic criteria tool needed
2

for a definitive diagnosis. For years, disagreements took place over the legitimacy and the
need for a diagnostic label. What would be the classification, what division of medicine
would take ownership, and what treatment protocols and options would benefit the FM
population are just a few of the questions posed by the medical community (Häuser &
Fitzcharles, 2018).
Chen and McKenzie-Brown’s (2015), research estimated that about 2% of the
population meets the 2010 modified diagnostic criteria of the American College of
Rheumatology (2021) for fibromyalgia syndrome in the developed world's population.
FM occurrence is higher in women, although it also occurs in children and men. All
ethnic groups are affected and may affect other family members between the ages of 20
to 50. Incidences of FM rise with age; by age 80, about 8% of the adult population in the
world meet the American College of Rheumatology classification of fibromyalgia.
Despite these research findings, many providers doubt FM diagnosis and point to
depression, pain, or insomnia as the main issues of the FM population (Chen &
McKenzie-Brown, 2015).
Problem Statement, Clinical Question, and PICOT
According to a survey conducted by primary care providers, as many as twothirds of these providers have problems distinguishing FM from other disorders and were
not well trained in FM diagnosis (Arnold et al., 2011, p. 8). Providers in primary care
manage many complex chronic diseases, and FM diagnosis and treatment should occur in
primary care. The FM diagnosis often does not occur due to providers' lack of knowledge
regarding FM and there are not any clear guidelines for management. Every FM patient
has to be treated as an individual.
3

There is a significant knowledge gap of providers in primary care settings that
causes delays in diagnoses and treatment for those with the complex array of symptoms
that accompany FM (Arnold et al., 2016). According to Arnold et al. (2016), research
providers who suspect FM will refer to a rheumatologist or other providers to diagnose
and provide treatments. The knowledge gap is related to uncertainty, unavailability, or
unawareness of the ACR diagnostic criteria screening tool.
Database searches were performed to find evidence-based research on the PICOT
question: PICO (T) Question: does educating providers on the availability and use of the
ACR preliminary diagnostic criteria screening tool in primary care improve the provider's
confidence in their ability to diagnose fibromyalgia in primary care?
Available Knowledge
Management of complex chronic diseases by providers in primary care is routine,
and patient referrals as needed for a patient-centered approach to providing care. These
same criteria should apply to FM as a chronic disease where education is necessary, is
incorporated into treatment goals, and continued follow-up applies. In managing the FM
population, the provider must consider more than one treatment goal; treatment is longterm and requires a strategic approach for each person’s array of symptoms.
The provider must treat all symptoms to effectively manage the FM population
(Arnold et al., 2012). Many providers often avoid FM patients due to the complexity of
the illness and later refer to specialists as quickly as possible. The time needed to educate
patients regarding FM is not cost-effective. The routine follow-up visits are usually
lengthy and may cause diminished reimbursements, increase overhead, and bureaucratic
demands. Providers performing a complete medical history, physical examination, using
4

the ACR diagnostic criteria tool, and blood work to rule out other diseases can quickly
diagnose FM in most patients (Fitzcharles et al., 2018).
According to Fitzcharles et al. (2018), FM is a chronic illness with various
symptoms. Hence, the FM population needs long-term, continuous care and knows that
treatment goals will change over time based on the ongoing evaluation. Almost all care
providers in primary care are qualified to manage FM patients, and FM patients should
only refer to a rheumatologist, psychiatrist, psychologist, or other specialists if needed
(Fitzcharles et al., 2018).
Instead, the new criteria require the examiner to fully assess the patient's concerns
and perform a thorough physical examination. It is impossible to know the extent of
unrefreshed sleep, fatigue, cognitive issues, and degree of pain without a detailed
interview and the use of a diagnostic screening tool as part of the protocol to diagnose
FM. The 2010 ACR diagnostic criteria screening tool obligates the provider to focus
extensively on the subjective complaints to give a definitive diagnosis of FM (Wolfe,
2010) (see Appendix A).
Galvez-Sánchez and Reyes del Paso (2020) conducted a research study that shows
88.4% sensitivity and specificity of 81.1% using 1990 ACR criteria to screen for FM will
differentiate FM from other rheumatic conditions. With rheumatoid arthritis (RA) and
osteoarthritis (OA), the ability to distinguish from FM with the sensitivity of 96.6% and
the specificity of 91.8% Sánchez and Reyes del Paso (2020). In 2010, the ACR
diagnostic criteria for diagnosing FM cut-off value of WPI increased from greater than or
equal to 14 from 7 and SS from greater than or equal to 5 to 7 with 100% diagnostic
accuracy for FM Galvez-Sánchez and Reyes del Paso (2020).
5

Furthermore, all patients recruited with the 1990 criteria fulfilled the 2010
criteria, suggesting a good diagnostic agreement between both sets of criteria (GalvezSánchez & Reyes del Paso, 2020). When the 2010 ACR criteria cut-off values were
maximized up to WPI ≥ 14 and SS ≥ 7, specificity and diagnostic accuracy of 100% were
achieved (Galvez-Sánchez & Reyes del Paso, 2020). Studies using logistic regression
analysis showed that the ability to discriminate between FM and RA patients was higher
for the WPI (95.9% overall accuracy) than for the SS (87.1% overall accuracy) (GalvezSánchez & Reyes del Paso, 2020).
Galvez-Sánchez and Reyes del Paso (2020) conducted a research study that shows
88.4% sensitivity and specificity of 81.1% using 1990 ACR criteria to screen for FM will
differentiate FM from other rheumatic conditions. With rheumatoid arthritis (RA) and
osteoarthritis (OA), the ability to distinguish from FM with the sensitivity of 96.6% and
the specificity of 91.8% Sánchez and Reyes del Paso (2020). In 2010, the ACR
diagnostic criteria for diagnosing FM cut-off value of WPI were increased from greater
than or equal to 14 from 7 and SS from greater than or equal to 5 to 7 with 100%
diagnostic accuracy for FM Galvez-Sánchez and Reyes del Paso (2020).
Needs Assessment
There are gaps in FM research compared to other chronic illnesses, including
diabetes, rheumatoid arthritis, and asthma; thus, this has caused some providers to be far
behind in their understanding and therapeutic approaches to FM (Clauw et al., 2017). The
ACR published the first diagnostic criteria for classification for FM in 1990, requiring a
definitive diagnosis of FM to have at least eighteen of the tender points on the body and
widespread pain for at least three months (Wolfe, 2010). This 1990 ACR assessment
6

evaluates the tenderness points on the body according to defined thresholds. With this
assessment, there must be at least eleven tender points of eighteen points and widespread
pain for at least three months (Wolfe, 2010). The provider could assess the tender points
by applying a standardized pressure of 4 kg to turn a thumbnail white to the tender points,
and three months of these symptoms (Wolfe, 2010).
Carol Burckhardt and Sharon Clark at Oregon Health and Science University in
Portland, Oregon, published the Fibromyalgia Impact Questionnaire (FIQ) in 1991. The
FIQ attempted to teach the spectrum of fibromyalgia problems and therapy responses
because fibromyalgia’s clinical features were just being discovered. Since that time, it has
been extensively used to index disease activity and therapeutic efficacy (Bennett et al.,
2009).
However, after two decades, the ACR proposed new criteria in 2010, which
removed the Revised Fibromyalgia Impact Questionnaire (RFIQ) tender points. The
RFIQ is an updated version of the FIQ with excellent psychometric properties, and can be
completed in less than 2 minutes, and is easy to score. The RFIQ has scoring
characteristics comparable to the original FIQ, making it possible to compare past FIQ
results with future RFIQ results (Bennett et al., 2009).
Research has shown that healthcare providers may overlook rheumatic disorders
that have inaccurately been diagnosed as FM. In 2010, the ACR introduced new
diagnostic criteria. The new diagnostic criteria require the provider to fully examine the
patient’s problem list to obtain a clearer path to a definitive diagnosis. This DNP project
aims to educate providers on the diagnostic criteria tool's availability and how to use the
tool. (Arnold et al., 2011).
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This DNP project endeavors to provide data indicating that using the screening
tool will improve making definitive diagnoses. The decisions that providers make about
diagnosis, treatment, prescribing, referrals, and tests are based on the healthcare
provider's knowledge, their confidence in that knowledge, and their experiences using the
knowledge. FM is a complex condition in which the population presents with multiple
symptoms, where adequate education and diagnostic screening tools must be used with
chronic pain patients to give a definitive diagnosis early (Arnold et al., 2010).
Wolfe's (2010) study reveals that the new diagnostic criteria for FM eliminate the
tender point examination because, of difficulty to perform for some providers, causing
distractions and delays in diagnosing. With the new ACR diagnostic criteria, eleven
tender-point exams were removed and replaced with the WPI, proving more information
regarding the extent and threshold of pain. Eliminating the tender points exam does not
suggest that physical examination is no longer required for patients, nor does the removal
of the eleven tender points lighten the provider's role in the diagnosing of FM. Instead,
the new criteria require the examiner to fully assess the patient's concerns and perform a
thorough physical examination. It is impossible to know the extent of unrefreshed sleep,
fatigue, cognitive issues, and degree of pain without a detailed interview, and the use of a
diagnostic screening tool as part of the protocol to diagnose FM. The 2010 ACR
diagnostic criteria screening tool obligates the provider to focus extensively on the
subjective complaints to give a definitive diagnosis of FM (Wolfe, 2010) (see Appendix
A).
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Synthesis of Evidence
Fibromyalgia FM has a negative and substantial impact on the lives of patients
and families. FM can affect the quality of life and dramatically changes the person's
ability to independently perform vital personal needs and affect family, friends, and
employer's relationships (Arnold et al., 2008). FM may be so debilitating that the person
may become incapacitated and unable to work to the point of requiring assistance with
activities of daily living. Fibromyalgia is the most common chronic pain condition,
second only to osteoarthritis, and worldwide, FM affects all ethnic and medical
communities in the same measure. According to the National Fibromyalgia Association
(NFA, 2015), FM cost is very costly for individuals and society due to its debilitating
nature and multiple symptoms. Hence, the need for early diagnosis and treatment is
essential for all stakeholders. The initial plan has to be to identify the diagnosis of FM,
start treatment timely and rule out or confirm other comorbidities (Arnold et al., 2008).
A research study conducted by Arnold et al. (2011) found that despite some
improvement in understanding the process of FM and its pathologic as many as 3 out of 4
people with FM-like symptoms remain undiagnosed and undertreated. From the
beginning of symptoms to the time of diagnosis may take an average of 5 years with
potential suboptimal medical care and delay in treatment. Hence, a vital part of successful
management is establishing FM's diagnosis early and starting treatment (Arnold et al.
2011). Providers in primary care see more patients with undiagnosed FM than are any
other providers (Arnold et al., 2011). When FM is diagnosed, both providers and patients
can see a clear path to overcome a significant hurdle to manage the disorder effectively
together (Arnold et al., 2011).
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Arnold et al. (2011) state the evaluation to diagnose FM may take more time than
allowed for a patient routine visit, but providers in primary care should not let this fact be
a barrier in their practices. If FM is suspected or confirmed, treatment should begin
immediately, and the evaluation has to continue for possible coexisting disorders (Arnold
et al., 2011). In this same research study, Arnold et al. (2011) found that improving
recognition and diagnosing FM is essential. FM can affect the quality of life and become
a burden on the economy due to remaining underdiagnosed as well as undertreated even
with increased awareness and interest in the disorder (Arnold et al., 2011).
Migraine headaches and back pain are chronic pain illnesses similar to FM, and as
such, it is appropriate for providers in primary care to diagnose and treat FM (Arnold et
al., 2011). A research study on the ACR diagnostic criteria screening tool states that the
tool will assist with an early diagnosis, treatment and increasing the provider's
confidence. Using the ACR diagnostic criteria to diagnose or rule out FM will allow the
provider in primary care to explore and make other diagnoses of other diseases with
similar symptoms (Arnold et al., 2011).
In practice, primary care providers are often the first health professionals the FM
population patients consult regarding their many symptoms causing such poor quality of
life (Baron et al., 2014). The ACR recommends that their diagnostic criteria screening
tool be used in addition to the patients' symptoms, comorbidities, medical history, and the
results of laboratory tests in primary care to establish a diagnosis. Because incorrect
diagnosis remains very frequent, patients are likely to undergo multiple consultations and
referrals before receiving a positive diagnosis and adequate care management. Delayed or
misdiagnosis, along with the condition itself, has a significant impact on a patient's
10

emotional state and quality of life, society, and health care costs (Baron et al., 2014).
ACR diagnostic criteria are widely available and are very sensitive to confirming FM, but
the criteria are rarely used to establish FM diagnosis.
Hence, using the ACR diagnostic criteria screening tool, the primary care
provider will translate patients' complaints and experiences into clues to help the provider
manage the patient in primary care. Baron et al. (2014), created a scoring method using a
series of repeating steps for the process based on statistical and clinical considerations
with the American College of Rheumatology called FibroDetect. The study included FM
patients and non-FM patients. The FibroDetect tool included fourteen questions assessing
patients' pain and fatigue, personal history and attitudes, symptoms, and impact on lives.
A FibroDetect tool was found to have a 90% sensitivity and specificity of 67% (Baron et
al., 2014). In contrast, the ACR diagnostic screening tools remain the best choice because
it has sensitivity and specificity for the criteria to 90.2% and 89.5% (Baron et al., 2014).
Arnold, Gebke, and Choy's (2016) systematic review revealed that for most FM
diagnoses to occur in primary care, providers must have the training and access to
screening tools and assist with recognizing FM, providing the provider with the
confidence needed to identify and diagnose FM. According to Arnold et al. 2016,
providers in primary care received little training in basic pain assessment or management
of chronic pain. If the appropriate training has been provided to primary care providers, it
is too brief to be helpful or remembered. Additional ongoing training is most likely
needed for primary care providers and can be obtained by some form of regularly
scheduled continuing education on assessing pain and FM (Arnold et al., 2016).
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Delay in diagnosing FM might be the lack of knowledge of diagnostic criteria
screening or the lack of time allotted for patient visits in primary care is not enough for
the FM patient to discuss all of their symptoms. The many symptoms associated with FM
have to be discussed and evaluated (Arnold et al., 2016). As patients might on the
visitation present with one or two symptoms commonly associated with FM, such as lack
of interest in things that once caused pleasure, chronic fatigue syndrome, a provider must
be sure to inquire about pain as a part of the assessment even if the patient does not report
the pain (Arnold et al., 2016). The ACR diagnostic criteria screening tool could improve
diagnostic accuracy, reduce delays in initiating treatment and provide education for the
FM patients. Patient education is essential in aiding in the understanding, acceptance, and
learning to self-manage FM (Arnold et al., 2016). According to Arnold et al. (2016), the
primary care provider's role is unique with the FM patients, and forming a therapeutic
relationship between the provider and the patient is necessary to provide needed support
for the FM patient. The WPI and SS, part of the ACR preliminary diagnostic screening
tool, should be completed at every visit. This will help providers have the subjective
information from the patient, Arnold et al. (2016). When the WPI and SS part of the form
is completed by the FM patient and reviewed with the patient at each visit by the primary
care provider, communication between patients and providers will improve, causing a
trustful therapeutic relationship (Arnold et al., 2016).
According to Arnold et al. (2016), the primary care provider is unique and must
form a therapeutic relationship that provides support. The use of the ACR diagnostic
screening tool at every visit, which consists of scoring of WPI and SS, will also help
patients’ education. When the form is completed and reviewed with the patient at each
12

visit, it improves communication between the patient and provider. Poor communication
may cause frustration in the patient leading to over-reliance on pharmacological
interventions with little benefit.
The ACR diagnostic criteria will provide a guideline for early diagnosing and
early treatment for all patients who present with chronic pain. The ACR will also help
relieve the provider's insecurities in diagnosing and treating (Arnold et al., 2016). FM is a
clinical diagnosis that a primary care provider should make based on the disorder's
clinical characteristics (Arnold et al., 2016). Prompt symptom recognition leads earlier,
leading to an earlier starting of treatment using the ACR diagnostic criteria screening tool
for all patients who present with chronic pain complaints (Arnold et al., 2016).
Bernstein’s 2015 article states that in the diagnosis of FM, there is no disease to
cure. FM, a complex illness that speaks to overwhelming pervasive symptoms, and often
symptoms are more significant than are experienced by patients with organ system
diseases such as heart failure and some cancers. The provider's role is not to question or
denigrate the patient's motives but to understand the context in which they suffer and
comprehend the disease's nature. Since there is no disease to cure, there must be aid and
support in times of hardship and distress to address FM's symptoms.
Historically, the concepts about fibromyalgia were incorrect. It was believed that
FM was a disease of yes or no. This response is untrue because individuals in this
population have different levels or volume control settings for sensory processing in their
brains. The higher this volume or level is, the more pain response that comes from the
brain. This response causes FM patients to rate their pain as mild, moderate, severe, or
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unbearable FM patients and can change daily in severity. Making FM an indistinct
disease of fluctuating symptoms (Fitzcharles et al., 2018).
There has been a huge surge in the research studies conducted on FM for the past
thirty years. This research surge might be in part to the stakeholders' increase in
knowledge and interest, including patients with FM, their families, organizations labeled
self-help, the pharmaceutical industry, researchers, and providers (Häuser & Fitzcharles,
2018). Before a condition can be recognized as a disease, the World Health Organization
(WHO) must officially recognize it. In 1992, the WHO recognized FM as a disease. In
1994, in the 10th revision of the International Classification of Diseases (ICD-10), FM
was listed as a musculoskeletal system disease and connective tissue with ICD 10 code of
M79.7 (Häuser & Fitzcharles, 2018).
Despite the legitimacy of FM by WHO, there are healthcare providers that do not
believe that FM exists. Many are diagnosed with FM when other providers for other
conditions are being told that FM does not exist. This issue is, in part, believed to be
because there are not any objective findings to diagnose FM. FM must be diagnosed by
subjective data collected from those presenting to see a provider with their many
symptoms (Häuser & Fitzcharles, 2018).
According to (WHO), FM is a real disease, a legitimate disease in the pain field,
but the literature still shows doubter. FM is the poster child for a common type of pain
originating from the brain and central nervous system rather than ongoing tissue damage
inflammation. Why is it so difficult for providers to believe that FM pain originates from
the brain while we readily accept phantom limb pain and headaches? Many chronic pain
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conditions such as fibromyalgia, irritable bowel, TMJ disorder, interstitial cystitis are
believed to originate from the brain, not from peripheral tissues.
Just as many other chronic pain syndromes are diagnosed and treated by providers
in primary care, so should FM. Some of the discomforts present in diagnosing and
treating FM are because the problem deviates from providers' normal training on tissue
and organs. FM individuals feel any sensory experiences as more painful and unpleasant
than would occur peripherally in those without FM because the problem is that the
volume control for sensory processing is higher in the brain (Bernstein 2015).
Search
A systematic, electronically strategic search was conducted to capture the most
relevant research for diagnosing FM. An electronic search of databases that included
Medline search, EBSCOhost, Cochrane Reviews, and Google Scholar to access peerreviewed articles. The purpose of the searches was to find peer-reviewed articles related
to diagnosing FM in primary care. The terms related to the PICOT questions were
searched: primary care, fibromyalgia, chronic pain, evidence-based practice, economic
burden, screening tools, protocols, and diagnostic criteria for adults 18 years and above.
Because a primary care setting is usually the first appointment that the FM population
makes and presents to the provider with multiple symptoms, including CPS, and steadfast
health concerns they have had to endure for many years. It is essential to diagnosing FM
early by determining whether providers in primary care are aware of the diagnostic
criteria tool. If the diagnostic criteria tool is used by providers in the primary care setting
to screen for FM in patients with complaints of chronic pain, to ensure that early
diagnosis and treatment will occur.
15

Focused Topics and Evidence-Based Findings
Management of FM in primary care may be challenging for providers even
though much evidence-based research about the underlying pathophysiologic
mechanisms involved in FM is available. (Fitzcharles et al., 2018). When providers find
it challenging to identify and diagnose FM, this prevents them from communicating this
information to patients. Despite this, there is a growing recognition of FM by patients
with many symptoms, so more people seek medical help and make frequent visits to
providers in primary care (Fitzcharles et al., 2018). Thus, FM is a problem commonly
seen in primary care that decreases the quality of life and becomes an economic burden.
With time and resources limited in primary care clinics, those presenting with multiple
symptoms accompanying FM may be perceived as complex, especially since
standardized treatment protocols are unavailable (Fitzcharles et al., 2018).
Arnold et al. (2012) report that FM is a chronic disease that significantly affects
several parts of a patient's life, including engaging in work and everyday activities, which
may lead to some FM patients being perceived as challenging to treat by their providers.
However, it is important to assess all areas that are impacted by symptoms of FM and to
work collaboratively with the patient in a patient-centered approach during follow-up to
prioritize goals for treatments (Arnold et al., 2012). Pain and symptoms of FM may be
assessed using the ACR WPI and SS scale. These scales will evaluate and validate pain,
cognitive and physical abilities, and other health-related quality of life assessments
(Arnold et al., 2012). Using the ACR assessment tools to assist with goal setting when a
patient is diagnosed with FM will give the provider a baseline of health status. Progress,
decline, or improvements can be monitored at each visit using this tool (Arnold et al.,
16

2012). Other tools are available that providers may use to assess the impact of FM on
patients'. The Fibromyalgia Impact Questionnaire (FIQ) and the revised version (RFIQ).
The RFIQ considers three areas: function, effect, symptoms; it takes less than 2 minutes
to complete. In 2010, a new version of the diagnostic criteria based on the WPI and SS
scales was introduced by the ACR (Galvez-Sánchez & Reyes del Paso, 2020).
The ACR criteria introduced the SS scale, the development of scales based on the
2010 criteria, which help with diagnosis and evaluation of the severity of the disease, and
measures the extent of fatigue, unrefreshed sleep, cognitive problems, and diversity of
symptoms. (Galvez-Sánchez & Reyes del Paso, 2020). The SS score correlates with the
widespread pain index (WPI) at 0.733, and the tender point counts at 0.680 and is used as
part of FM criteria. (Galvez-Sánchez & Reyes del Paso, 2020). These scales fully capture
the actual content of fibromyalgia for the provider. (Galvez-Sánchez & Reyes del Paso,
2020). The modifications have improved the sensitivity and specificity for the criteria to
90.2% and 89.5%, respectively. The scale captures the differences in the severity of
symptoms in all patients (Galvez-Sánchez & Reyes del Paso, 2020).
The ACR criteria introduced the SS scale based on the 2010 criteria, which helps
diagnose, evaluate the severity of the disease, and measure the extent of fatigue,
unrefreshed sleep, cognitive problems, and diversity of symptoms. (Galvez-Sánchez &
Reyes del Paso, 2020). The SS score correlates with the widespread pain index (WPI) at
0.733, and the tender point counts at 0.680 and is used as part of FM criteria. (GalvezSánchez & Reyes del Paso, 2020).These scales fully capture the actual content of
Fibromyalgia for the provider. (Galvez-Sánchez & Reyes del Paso, 2020). The
modifications have improved the sensitivity and specificity for the criteria to 90.2% and
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89.5%, respectively. The scale captures the differences in the severity of symptoms in all
patients (Galvez-Sánchez & Reyes del Paso, 2020).
The ACR criteria introduced the SS scale, the scale which is based on the 2010
criteria, which helps to diagnose and evaluate the severity of disease, and the extent of
fatigue, unrefreshed sleep, cognitive problems, and diversity of symptoms are measured
(Galvez-Sánchez & Reyes del Paso, 2020). The SS score correlates with the widespread
pain index (WPI) at 0.733, and the tender point counts at 0.680 and is used as part of FM
criteria (Galvez-Sánchez & Reyes del Paso, 2020). These scales fully capture the actual
content of Fibromyalgia for the provider. (Galvez-Sánchez & Reyes del Paso, 2020).
Modifications to the criteria' forms, sensitivity, and specificity, have improved to
90.2% and 89.5%, respectively (Galvez-Sánchez & Reyes del Paso, 2020). These scales
capture the differences in the severity of symptoms in all patients (Galvez-Sánchez &
Reyes del Paso, 2020). According to Wolfe (2010), using the 2010 ACR classiﬁcation
criteria was performed well in primary care, specialty clinics and provided patients
homogeneity for clinical trials. However, providers in primary care are slow to embrace
the criteria. This lack of criteria use may be due to the lack of education on the ACR's
diagnostic criteria changes.
The project's goal was that the providers would evaluate and diagnose FM early in
primary care clinics. The new practice strategy will improve the delay in initial
diagnosing, starting treatment, and earlier referrals if needed. The benefit of using the
diagnostic tool from the ACR is to decrease the time necessary to diagnose FM, improve
provider knowledge of diagnosing FM, and encourage the starting of treatment early by
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providers in primary care (Wolfe 2010). Early diagnosis will lessen the economic burden
and the stress of the FM population.
In, Mexico, 6 European countries, and South Korea, a questionnaire survey of
1622 physicians were conducted by Perrot et al. (2012) that included primary care
physicians, rheumatologists, neurologists, psychiatrists, and pain specialists. Results were
that greater than 80% of the providers had seen a patient with FM in the past year. Perrot
et al.'s (2012) result revealed that only 32% did not know about FM. More than 53%
reported difficulty when it comes to diagnosing FM. Only 32% lacked knowledge of the
American College of Rheumatology classification criteria. FM is challenging to diagnose
and manage (Perrot et al., 2012). Many providers are not confident in developing a
treatment plan and managing FM patients long-term (Perrot et al., 2012).
Rationale, Theoretical Framework, Models, Concepts/Theories
The Common-Sense Model of Self-Regulation (CSM) is a widely used conceptual
framework that explains the processes by which patients with chronic diseases become
aware of a health threat. The CSM helps an individual navigate effective responses to the
threat, then formulate perceptions of the danger and potential treatment actions. Thereby,
they can create action plans for addressing the risk and integrate continuous feedback to
evaluate the action plan and threat progression (Leventhal et al., 2016).
The CSM model captures the layperson's understanding of their bodily changes or
symptoms and focuses on five domains of symptoms: 1) identification of symptoms as an
illness, 2) causes of the symptoms, 3) the timeline of how long the disease will last or the
seriousness of the condition, 4) consequences of the disease and its symptoms, and 5)
curability/controllability or what they will be able to do about the illness or symptoms
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(Leventhal et al., 2016). The CSM may be used in chronic medical conditions when there
was no apparent pathophysiological explanation, high uncertainty, lack of a productive
cure, and has a high incidence of emotional problems. Providers' decisions about
diagnosis, referrals, tests and prescribing are influenced by the providers' perceptions and
vary between providers. Thus, while there is ambiguity over the diagnostic criteria for
FMS, variations in clinicians' beliefs will determine the care patients receive (Pastor et
al., 2012).
Regardless of practice size, age of practice, or specialty of practice, change plays
an influential role in any healthcare practice. Kurt Lewin developed his change method
theory in the 1940s, and his ideas of evolution and motivation in the workplace are very
relevant in this century. Lewin's theory will work well in most practices because change
is an ongoing process and involves action planning, fact-gathering, and communicating
throughout each of his three stages of change, known as unfreeze, movement, and
refreeze (Hussain et al., 2018).
The process ensures more precise expectations and shared understandings for
those involved and affected by the desired change (Hussain et al., 2018). In Lewin's
theory, unfreezing disrupts the current processes that are in place and introduce the
expected or desired change (Hussain et al., 2018). The second stage, called a movement,
or change, requires people to adopt the new process or change by promoting active
involvement and open communication. The third stage, refreeze, reinforces the unique
patterns of behaviors to sustain the transition by providing ongoing support, follow-up,
and assistance to individuals using a new process (Hussain et al., 2018).
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Lewin’s Change Theory Applied
This DNP project’s unfreezing stage involved educating working providers in a
primary care setting to learn the importance of using the ACR preliminary diagnostic
screening tool for those who present with chronic pain. The providers were given a preeducational screening questionnaire. The stakeholders are the providers in the primary
care clinic who also own the clinic, so their involvement was crucial to the process of
unfreezing (Porter-O’Grady & Mallach, 2015).
The change phase of this DNP project was the providers’ education on using the
diagnostic criteria screening tool. A virtual education was provided by a voice-over
PowerPoint explaining the tool’s use and how the tool is scored. The providers were
given a chance to ask questions and review their answers to the questionnaire (PorterO’Grady & Mallach, 2015).
Finally, in the unfreezing phase, the provider was willing to incorporate the use of
the ACR diagnostic criteria screening tool for all who present with chronic pain
complaints. A post-educational questionnaire was given to the providers and reviewed
(Porter-O’Grady & Mallach, 2015).
Specific Aims
According to Wolfe (2010), using the 2010 ACR classification criteria was found
to have performed well in primary care, specialty clinics and provided patients
homogeneity for clinical trials. However, providers in primary care are slow to embrace
the criteria. This lack of criteria use may be due to the lack of education on the ACR's
diagnostic criteria changes.
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The project's goal was that the providers would evaluate and diagnose FM early in
primary care clinics. The new practice strategy will improve the delay in initial
diagnosing, starting treatment, and earlier referrals if needed. The benefit of using the
diagnostic tool from the ACR is to decrease the time necessary to diagnose FM, improve
provider knowledge of diagnosing FM, and encourage the starting of treatment early by
providers in primary care (Wolfe 2010). Early diagnosis will lessen the economic burden
and the stress of the FM population.
Early diagnosis can improve anxiety, reduce depression, and prevent ER visits
due to pain and other symptoms that may occur when diagnosing is delayed. This DNP
project's measurable objective is the early diagnosis and treatment of patients with FM by
providers in primary care will be improved to at least 90% (Wolfe, 2010). FM should be
considered in patients who present in primary care with mood changes, chronic pain,
unrefreshed sleep, and fatigue, even though the symptoms can represent a diagnostic
challenge. Many of these patients may meet the fibromyalgia criteria (Fitzcharles et al.,
2018). However, due to the lack of education of the provider of the diagnostic criteria
that can be used by the provider, it can be potentially frustrating in diagnosing and
management in primary care. Recent studies have improved our understanding of the
diagnostic criteria by using the ACR diagnostic criteria tool. Education of providers will
lead to early diagnosis, improve the provider's confidence, and lead to significant and
appropriate management of FM in primary care (Fitzcharles et al., 2018).
Doctor of Nursing Practice Essentials
The Doctor of Nursing Practice (DNP) Essentials outlines foundational
competencies fundamental to advanced nursing practice roles. DNP Essentials include
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scientific underpinnings for practice organizational and system's leadership for quality
improvement and systems thinking; clinical scholarship and analytical methods for
evidence-based practice; information systems technology and patient care technology for
improvement and development of transformation of health care; health care policy for
advocacy in healthcare; interprofessional collaboration for improving patient and
population outcomes; clinical prevention and population health for improving the
nation’s health and advance the nursing practice (AACN, 2006). All eight elements are
essential, but Essentials I, II, III, and VIII were mainly addressed by this DNP project.
DNP Essential I: Scientific Underpinnings for Practice: Essential I is met using
the diagnostic criteria for fibromyalgia from the ACR. The common-sense model guides
the project as an educational tool. Lewin's theory will work well in most practices
because change is an ongoing process and involves action planning, fact-gathering, and
communicating throughout each of his three stages of change, known as unfreeze,
movement, and refreeze
DNP Essential II: Organizational and Systems Leadership for Quality
Improvement and Systems: The essential was met after assessing the site’s needs. It led
to providing evidence-based training to the providers to improve patients’ quality care by
educating them on diagnostic criteria to diagnose fibromyalgia recommended by the
ACR. Therefore, the enhancement of providers' education on the need for diagnostic
criteria will lead to an early diagnosis and treatment of fibromyalgia.
DNP Essential III: Clinical Scholarship and Analytical Methods for Evidencebased Practice: Essential III was met by promoting the ACR recommendation as an
educational tool as an intervention for the providers to use to improve patient outcomes.
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It was also reached by analyzing various literature to decide the right approach for this
project. The providers were given a copy of the diagnostic criteria after a pre-educational
survey/questionnaire of the provider’s confidence in diagnosing FM.
DNP Essential VIII: Advanced Nursing Practice: Essential VIII was met by
moving forward with this project to educate the providers on the diagnostic criteria
according to the ACR to diagnose fibromyalgia. Educating providers on the diagnostic
criteria tool will improve the screening and diagnosing of fibromyalgia by an evidencebased tool.
Summary
The ACR has questionnaires designed to assess and validate pain, and it can also
evaluate health-related quality of life such as physical, cognitive, and emotional in FM
patients (Arnold et al., 2012). Using these questionnaires as part of each visit assessment
can give a baseline health status and updated health status and aid in setting goals that the
patient and the provider may monitor progress. The patient fills in these questionnaires
when visiting a doctor (Arnold et al., 2012).
These Questionnaires designed to assist with diagnosing fibromyalgia include the
Fibromyalgia Impact Questionnaire (FIQ) and the revised version (FIQR) (Arnold et al.,
2012). The RFIQ assesses (functional abilities, symptoms, and the symptoms' impact on
the patient) using 21 check-box questions completed in less than 2 minutes (Arnold et al.,
2012).
The new ACR version of the preliminary diagnostic criteria screening tool in
2010 was based entirely on two scales: the Symptom Severity (SS) Scale and the
Widespread Pain Index (WPI) Galvez-Sanchez & Reyes del Paso, 2020). These two
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scales were added to the preliminary diagnostic criteria screening tool by the ACR and
may be used at each visit as part of the patient's assessment. Using these two scales will
let the patient and the provider know their current health status (Galvez-Sanchez & Reyes
del Paso, 2020). Educating providers in a primary care setting on the availability of these
screening tools and using the tools is the project's goal.
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CHAPTER II - METHODOLOGY
In introducing this intervention to the primary care clinic, the researcher must
communicate educational intentions while informing the providers of the need to use the
diagnostic tool for diagnosing FM. Patients presenting to primary care clinics with
complaints of widespread generalized chronic pain patients should be screened for FM. If
screening of these patients occurs this will help eliminate or decrease the length of time
the patient spends without a diagnosis. The FM patient experiences many symptoms so
much so it is hard to articulate all the symptoms to the provider. The ACR diagnostic
screening tool addresses widespread pain, the severity of symptoms, and the assessment
of the many somatic symptoms. Using this tool will aid the FM patient to have the ability
to see symptoms in print and answer accordingly.
Population and Sample
The population of focus for this project was all patients 18 years and above that
presented to the primary care clinic with complaints of widespread chronic pain (pain
more than three months). This project was completed in a rural health clinic in central
Mississippi. The ACR preliminary diagnostic criteria screening tool for FM will be used
as a part of the routine assessment of chronic widespread pain patients. There are two
providers in the clinic and they see between 40 and 50 patients a day.
Intervention
The availability and the use of the ACR diagnostic screening tool were the focus
of the synthesis of evidence. The interventions focused on improving recognition,
diagnosing of FM by the introduction of the ACR screening tool. This intervention will
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decrease the lack of knowledge of the ACR screening tool and provide education on the
tool.
Part 1. Retrospective chart review to determine the number of adults 18 years and
older experiencing widespread chronic pain for longer than three months. This chart
review was from January 1, 2020, to January 1, 2021, with a complaint of chronic pain
ICD 10 code G89.4 was conducted by the DNP student. The DNP student reviewed the
charts to see if the patients were diagnosed with FM and if a screening tool was used.
Part 2. The participants of the intervention were the primary caregivers working at
a rural health clinic in central Mississippi.
1. A pre-intervention questionnaire was sent to the providers via Qualtrics to be
completed. The consent form was included and had to be agreed to before the
pre-questionnaire could be completed.
2. A voice-over educational PowerPoint covering the history, diagnosing, and a
copy of the ACR preliminary diagnostic criteria for FM was sent to the
providers for review after the pre-intervention questionnaire was sent.
3. A post-intervention questionnaire was sent to providers via Qualtrics for
completion.
4. The providers were able to ask questions regarding intervention via Zoom.
Measures
A questionnaire, both pre- and post-education, was utilized to evaluate the level of
understanding of the diagnostic criteria for FM after the educational intervention was
completed. The providers were allowed to ask questions regarding the educational
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intervention via Zoom before the completion of the post-questionnaire. A copy of the preand post-education questionnaires is located in Appendix B.
Analysis
The DNP student was the only individual collecting data from the charts via
computer documentation software. The important data elements were identified,
recorded, and then organized into the form created by this DNP student. The information
gathered from the pre-education and post-education questionnaires were used to
determine the effectiveness of the educational intervention. Quantitative statistics were
utilized.
The question for evaluation for this DNP project was among patients 18 years and
above who present to primary care clinic with complaints of widespread chronic pain
lasting longer than three months, does educate providers on the availability and use of the
ACR diagnostic screening criteria tool, compared to not educating the providers in
primary care on the use and availability of the ACR diagnostic criteria tool, improve the
provider's ability to diagnose fibromyalgia in primary care?
Qualitative research methods look deeper into the problem to uncover trends in
thoughts. The interview method with providers was used before the project started, a pretest was sent to the providers to be completed in Qualtrics, and the education of the
providers took place by a voice-over PowerPoint presentation. After the voice-over
PowerPoint presentation, each provider was sent a post-test in Qualtrics to complete.
Ethical Considerations
The DNP project involved de-identified patient charts for review by this DNP
student. An Institutional Review Board (IRB) application was submitted and approved
28

by The University of Southern Mississippi (Protocol # IRB-19-591). The following
COVID-19 precautions were taken during the implementation of this DNP project: This
DNP student was the only researcher in a private area with access to the computer, 6 feet
social distancing, facial coverings, disinfecting surfaces before and after use, hand
washing, or hand sanitizer use. No additional contact was made. The project aims to
facilitate the early detection, diagnosis, and treatment of FM in those evaluated in
primary care using the ACR diagnostic screening tool. This new practice strategy will
improve the delay in initial diagnosing, starting treatment, and earlier referrals if needed.
The benefit of using the diagnostic tool from the ACR is to decrease the time needed to
diagnose FM, improve provider knowledge of diagnosing FM, and encourage the starting
of treatment early by providers in primary care. Early diagnosis will lessen the economic
burden and the stress of the FM population.
Data consists of all de-identified data that will be maintained on the researcher's
password-protected personal computer. The de-identified electronic data will be deleted
six months after all graduation requirements have been met (June 2022). Physical data
will be kept in a locked file cabinet at this researcher's home office and will be shredded
six months after graduation requirements have been met on June 30, 2022.
Fibromyalgia symptoms often mimic many other conditions. Determine the cause
of symptoms is the key to receiving a proper diagnosis for FM or other diagnoses. Some
providers are unaware of the change to eliminate the digital palpation of tender points as
part of FM's diagnostic criteria (Galvez-Sanchez & Reyes del Paso, 2020). FM is a severe
burden to persons, society and is a health problem that can lead to overdiagnosis,
overtreatment, or inadequate treatment of FM patients. Acceptance of FM by health
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professionals and the general public must be achieved, which will assist with proper
treatments, and decrease the burden on persons and society (Galvez-Sanchez & Reyes del
Paso, 2020). The project's focus outcome seeks to help with the knowledge of the change
by educating providers on using the latest ACR diagnostic criteria. Each provider can
inform their colleagues and their community of the new diagnostic criteria. Providers in
primary care can make an early diagnosis of Fibromyalgia, start treatment or rule out
Fibromyalgia, and search for other possible diagnoses.
A retrospective chart review could be done by another researcher three months
after this project to evaluate the use of the ACR diagnostic screening form and if
fibromyalgia is being diagnosed, in addition, are the patients being treated in the clinic or
referred?
Project Timeline
1. The researcher did a retrospective chart review of 18-year-olds previously seen
in the clinic complaining of chronic pain with ICD 10 code G89.4. The data were
collected from February 1, 2020, to February 1, 2021. The providers were sent a link to
complete a pre-questionnaire in Qualtrics where the consent was completed before the
questionnaire could be started.
2. The project was conducted over four weeks at a primary care clinic. All
patients presenting to the clinic with a complaint of chronic pain longer than three months
were assessed for fibromyalgia using the ACR diagnostic criteria. The scores of each
patient were calculated, and the provider reviewed the assessment with the patients.
3. The following week the voice-over PowerPoint was delivered to the clinic on a
jump drive for the providers to watch and send back to the researcher with questions
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added which were addressed in the executive summary that will be sent to the providers
after the project has been completed.
4. One week after the educational intervention was received back by the
researcher from the providers, they were sent a link to complete the post-questionnaire
questions in Qualtrics.
Summary
This DNP project was focused on educating providers in primary care clinics on
the availability of the ACR Preliminary Diagnostic Criteria for FM. Learning of the ACR
Diagnostic criteria will aid providers to assess, diagnose, and treat and/or refer as needed.
The ACR can become a part of the patient’s permanent chart and can be used as a
baseline for future visits. The form can measure improvements, remain the same, or be
improved upon. The next chapter discusses the results of this DNP project.
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CHAPTER III – RESULTS
The benefits of the providers participating in this DNP project: Fibromyalgia
affects as many as 4 million U.S. adults, which is 2% of the adult population. The cause
of fibromyalgia is not known, but it can be effectively treated and managed. This DNP
project aimed to educate providers in primary care on the availability and use of the
American College of Rheumatology (ACR) diagnostic criteria screening tool for
fibromyalgia. Early diagnosis can improve anxiety, reduce depression, and prevent ER
visits due to pain and other symptoms that may occur when diagnosing is delayed. The
benefit of using the diagnostic tool from the ACR is to decrease the time needed to
diagnose FM, improve provider knowledge of diagnosing FM, and encourage the starting
of treatment early by providers in primary care. Early diagnosis will lessen the economic
burden and the stress of the FM population. The educational voice-over teaching
regarding the use of the ACR preliminary diagnostic criteria for FM and a copy of the
form which was given to the providers. This information is evidence-based and provides
the providers with information and material to make decisions about patient care and
diagnosing FM. The goal of this DNP project focused on assuring evidence-based
education in the primary care clinic will be used to diagnose FM. The acknowledgment
of ethical considerations was maintained throughout the project. Results from the
retrospective chart review, Pre-Education and Post education Questionnaires, and
Executive Summary to Facility Administration are discussed in this chapter.
Results from Retrospective Chart Review
With the retrospective chart review, there were a total of 100 charts reviewed of
patients 18 years and above that were diagnoses with chronic pain between February 1,
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2020, and February 1, 2021. Out of the 100 charts reviewed with chronic pain, 30 were
diagnosed with fibromyalgia. With the 30 patients diagnosed with fibromyalgia 10 came
to the clinic already diagnosed with fibromyalgia and 20 were diagnosed by the providers
in the clinic. For those 20 patients that were diagnosed in the clinic by the providers the
10- point assessment was used to diagnose fibromyalgia.
Results from the Pre-Education Questionnaire
The intervention portion of this DNP project consists of a pre-intervention
questionnaire being completed by all providers in Qualtrics after electronically signing
the consent form to participate.
Table 1
Pre-Educational Findings
Questions

Responses of Yes

Responses of No

Are you confident in
diagnosing fibromyalgia?

6

3

Have you received adequate
training in diagnosing
fibromyalgia?

4

5

Do you screen patients for
fibromyalgia?

7

2

Do you screen chronic pain
patients for fibromyalgia?

5

4

Do you use a screening tool/s
to diagnose fibromyalgia?

4

5

If you are diagnosed with
fibromyalgia, do you treat
the patient?

5

4

If you are diagnosed with
fibromyalgia do you refer?

3

2
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Table 2
Post-Educational Findings
Questions

Responses of Yes

Responses of No

Has your confidence in
diagnosing fibromyalgia
changed?

7

0

Will you use the ACR
diagnosing criteria form on
all chronic pain patients?

7

0

Will you use the ACR
diagnostic criteria on the
patient with acute pain that
also complain of mood
changes and/or fatigue?

7

0

If you diagnose a patient with
FM will you treat or refer?

7

0

Will you use another method
to diagnose FM?

0

7

Results from the Post-Education Questionaire
Based on the findings of the post-education questionnaire, the providers are
confident in diagnosing, treating, and referring patients as needed. Seven out of 7
providers confidence in diagnosing fibromyalgia after the educational intervention.
Summary
Education of providers in primary care regarding the availability of the ACR
Preliminary Diagnostic Criteria form will increase the provider's confidence in
diagnosing FM (Wolfe, 2010). After the educational intervention part of this project, the
providers' confidence in their ability to diagnose FM increased from 66% to 100 %. The
next chapter will continue the discussion.
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CHAPTER IV – DISCUSSION
Based on the results of the pre-education questionnaire, the providers lack the
confidence to diagnose FM. Before the educational intervention (66.67%) of the
providers answered yes to the pre-questionnaire question -are you confident in
diagnosing FM. After educational intervention (100%) of providers responded yes to post
questionnaire question-has your confidence in diagnosing FM improved.
Strengths and Limitations of the Project
One strength of the project was the provider's willingness to participate in the
project. If there is a limitation to the project, it would be the number of providers in the
clinic.
Key Findings
In the pre-educational questionnaire, 67% of the providers responded yes when
asked “are you confident in your ability to diagnose FM.” After the educational
intervention, the post-questionnaire shows that 100% of all participating providers
responded yes when asked if their confidence to diagnose FM improved. This DNP
project does answer the PICO question with yes educating providers in primary care in
the availability and usage of ACR preliminary diagnostic criteria does improve the
confidence of the providers to diagnose FM.
Impact of the DNP Project
This DNP project shows that educational intervention of the ACR preliminary
diagnostic criteria does improve providers' confidence in their ability to diagnose
fibromyalgia. Each provider at the clinic was forthcoming with their lack of knowledge
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of the ACR preliminary diagnostic criteria and their thankfulness for the introduction of
this form.
Summary
The goal of the DNP project was to improve the confidence of providers in primary care
clinics' ability to diagnose FM. The project did show that after an educational
intervention confidence will improve. The use of the ACR form will continue to facilitate
improved confidence by providers in primary care early diagnosing, treatment, and
referrals of FM as needed. A retrospective chart review can be done by another DNP
student 90 days after this DNP project to evaluate the use of the ACR diagnostic
screening form usage and if fibromyalgia is being diagnosed. Are the patients being
treated in the clinic or referred?
Conclusion
In conclusion, the project evaluated the effectiveness of the educational
intervention on the providers of this rural health regarding the use of the ACR
preliminary criteria for diagnosing FM. The project showed that when an educational
intervention that is focused on certain criteria is presented it does improve the provider’s
confidence. Another doctoral student can, at a later date, evaluate the overall
effectiveness of the use of the ACR preliminary diagnostics criteria for FM by doing a
chart review at a later date. The use of this form will facilitate early diagnosing, treatment
and referrals as needed.
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APPENDIX A – Clinical Diagnostic and Severity Criteria for Fibromyalgia: Widespread
Pain Index (WPI) and Symptom Severity (SS) Scale
Criteria
1.
2.
3.
4.

A patient satisfies diagnostic criteria for fibromyalgia if the following 3 conditions are met:
WPI ≥7 and SS scale score ≥5 or WPI 3-6 and SS scale score ≥9
Symptoms have been present at a similar level for at least 3 months.
The patient does not have a disorder that would otherwise explain the pain.

Ascertainment WPI (0-19)—
Directions: Note the number of areas in which the patient has had pain during the past week. In
how many areas has the patient had pain?
Left and Right Upper back Shoulder girdle
Left and Right Hip (buttock, trochanter)
Left and Right jaw
Lower Back
Abdomen
Chest
Left and Right Lower leg
Left and Right upper leg
Left and Right upper arm
Left and Right lower arm
SS scale score (0-12) = Symptom Severity + Extent of Somatic Symptoms Symptom severity—
Directions: Using the provided scale, indicate the level of severity experienced for each of the
3 following symptoms:
Fatigue
Waking unrefreshed
Cognitive symptoms
Scale 0 = no problem 1 = mild: slight, mild, or intermittent problems 2 = moderate:
considerable problems, often present and/or at a moderate level 3 = severe: pervasive,
continuous, life-disturbing problems
The extent of somatic symptoms—
Directions: Indicate how many somatic symptoms the patient has used the following scale 0 =
no symptoms 1 = few symptoms 2 = a moderate number of symptoms 3 = many symptoms

Somatic symptoms that might be considered include muscle pain, irritable bowel
syndrome, fatigue/tiredness, thinking or remembering problems, muscle weakness, headache,
pain/cramps in abdomen, numbness/tingling, dizziness, insomnia, depression, constipation,
pain in the upper abdomen, nausea, nervousness, chest pain, blurred vision, fever, diarrhea, dry
mouth, itching, wheezing, Raynaud phenomenon, hives/welts, ringing in ears, vomiting,
heartburn, oral ulcers, loss/change in taste, seizures, dry eyes, shortness of breath, loss of
appetite, rash, sun sensitivity, hearing difficulties, easy bruising, hair loss, frequent urination,
painful urination, and bladder spasms.
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APPENDIX B – Pre- and Post-Questionnaires
Pre-education questionnaire.
a. Are you confident in diagnosing fibromyalgia? Yes or No
b. Did you receive adequate training in diagnosing FM? Yes or No
c. Do you screen patients for fibromyalgia? Yes or No
d. Do you screen chronic pain patients for fibromyalgia? Yes or No
e. What screening tool/s do you use to diagnose fibromyalgia? 18 point, WPI, SS,
or
other tools/s
f. If you diagnose a patient with fibromyalgia? do you treat the patient or do you
refer the patient?

A pre-recorded video will be sent to the providers via email for review.

Post-education questionnaire.
a. Has your confidence in diagnosing FM changed? Yes or No
b. Will you use the ACR diagnostic criteria on all chronic pain patients? Yes or No
c. Will you use the ACR diagnostic criteria on the patient with acute pain?
Yes or No
d. If you diagnose a patient with FM will you treat or refer?
e. Will you use another method to diagnose FM? Yes or No
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APPENDIX C – Doctor of Nursing Practice Essentials
Essential I: Scientific Underpinnings for
Practice

This essential is met using the diagnostic
criteria for fibromyalgia from the ACR. The
common-sense model guides the project as
an educational tool. Lewin's theory will
work well in most practices because change
is an ongoing process and involves action
planning, fact-gathering, and
communicating throughout each of his three
stages of change, known as unfreeze,
movement, and refreeze.

Essential II: Organizational and Systems
Leadership for Quality Improvement and
Systems Thinking

The essential was met after assessing the
site’s needs. It led to providing evidencebased training to the providers to improve
patients’ quality care by educating them on
diagnostic criteria to diagnose fibromyalgia
recommended by the ACR. Therefore, the
enhancement of providers' education on the
need for diagnostic criteria will lead to an
early diagnosis and treatment of
fibromyalgia.

Essential III: Clinical Scholarship and
Analytical Methods for Evidence-Based for
Practice

This essential was met by promoting the
ACR recommendation as a screening tool
for the providers to use to improve patient
outcomes in primary care clinics.

Essential IV: Information
Systems/Technology and Patient Technology
for the Improvement and Transformation of
Health Care

This essential was met by suggesting that
the ACR form become a part of the EHR as
a screening tool and be used on all patients
with the complaint of chronic pain

Essential V: Health Care Policy for Advocacy
in Health Care

The project advocated for improving the
screening process for all patients that
present to primary care clinics with a
complaint of chronic pain.

Essential VI: Interprofessional Collaboration
for Improving Patient and Population

This project advocated for improving the
screening process for chronic pain patients
and asking the facility to consider adding to
EHR as an ongoing screening tool.
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Essential VII: Clinical Prevention and
Population Health for Improving the Nation’s
Health

The overall purpose of this project is the
early identification of fibromyalgia. It is an
attempt to aid primary care providers in this
process preventing years of debilitating
symptoms.

Essential VIII: Advanced Nursing Practice

This essential was met by moving forward
with this project to educate the providers on
the diagnostic criteria according to the ACR
to diagnose fibromyalgia. Educating
providers on the diagnostic criteria tool will
improve the screening and diagnosing of
fibromyalgia by an evidence-based tool.
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APPENDIX D – Synthesis of Evidence
Reference

Design

Ablin, J.,
A systematic
Fitzcharles, M., search
Buskila, D.,
Shir, Y.,
Sommer, C., &
Häuser, W.
(2013).
Treatment of
Fibromyalgia
Syndrome:
Recommendatio
ns of recent
evidence-based
interdisciplinary
guidelines with
special emphasis
on
complementary
and alternative
therapies.
Evidence-Based
Complementary
and Alternative
Medicine, 2013,
1-7.
https://doi.org/1
0.1155/2013/485
272

Sample

Findings

Recommendati
ons

Guideline
bibliographies
search was
manually
conducted to
verify that all
published
guidelines were
identified.

No therapy/
treatment will
cure FM. The
consensus is that
selfmanagement
strategies will
help patients
recognize and
adapt to
symptoms that
will preserve
and improve
daily function
and maintain
their quality of
life for FM
patients.
.

A patienttailored
approach that
follows
symptoms is
what all three
guidelines
emphasized.
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Arnold, L. M.,
Clauw, D. J., &
McCarberg,
B.H. (2011).
Improving the
recognition and
diagnosis of
Fibromyalgia.
Mayo Clinic
Proceedings,
86(5), 457-464.
https://doi.org/1
.4065/mcp.2010
0738

NA

NA

Fibromyalgia is
a diagnosis
similar to other
chronic pain
illnesses such as
migraine
headaches and is
appropriate for
primary care
providers to
diagnose in
primary care
clinics.

Patients with
FM can achieve
better health
outcomes and
quality of life.
Patients with
FM can
accomplish both
by their primary
care providers
providing
effective
treatment plans
based on an
increased
understanding of
the FM.

Arnold, L. M.,
Clauw, D. J.,
Dunegan, L. J.,
& Turk, D. C.
(2012). A
framework for
fibromyalgia
management for
primary care
providers. Mayo
Clinic
Proceedings,
87(5), 488-496.
https://doi.org/1
0.1016/j.mayocp
.2012.02.010

NA

NA

A framework for
primary care
providers to treat
patients with FM
effectively is a
part of the
multidisciplinary
approach to
improve
symptom
management,
health status,
patient
education, and
healthcare
outcomes. This
framework is
similar to the
integrated
approach taken
in the long-term
care of other
chronic health
conditions, such
as diabetes,
asthma, and
hypertension.

The approach
for FM
management
follows core
principles of
comprehensive
assessment,
education, goal
setting, and
multimodal
treatment. The
treatment
includes
pharmacological
, physical
activity,
education
similar to
managing other
chronic medical
disorders in
primary care.
Based on the
above
management
principles, this
review presents
a framework for
primary care
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providers to
develop a
patient-centered
treatment
program for
patients with
FM.
Arnold,
L.M.,Crfford, L.
J.,Mease, P.
J.,Burgess, S.
M.,Palmer, S.
C., Abetz, L., &
Martin, S. A.
(2008). Patient
perspectives on
the impact of
Fibromyalgia.
Patient
Education and
Counseling,
73(1), 114-120.
https://doi.org/1
.1016/j.pec.2008
06.005

Review the
epidemiology,
pathophysiology
, and
management of
FM by searching
PubMed
references from
articles and
selected papers
based on quality,
relevant to the
potential for
future
improvement,
importance in
illustrating
current
management
pathways, and
relevance to the
illness.

In which six
focus group
sessions with 48
women
diagnosed with
fibromyalgia
were conducted
to elicit concepts
and ideas to
assess the
impact of
fibromyalgia on
their lives.
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A peer-reviewed
journal supports
the conclusions
that FM is
significant in
illustrating
current
management
pathways and
the necessity for
future
improvements.

Implementing a
patient-centered
medical home
for managing
FM patients
would allow
these patients to
be successfully
managed in
primary care
clinics. Primary
care clinics
manage many
other chronically
diagnosed
patients, and
several barriers
have to be
overcome before
this can be
implemented.

Arnold, L. M.,
Gebke, K. B., &
Choy, E. H.
(2016).
Fibromyalgia:
Management
strategies for
primary care
Providers.
International
Journal of
Clinical
Practice, 70(2),
99-112.
https://doi.org/1.
1111/ijcp.12757

Review the
epidemiology,
pathophysiology
, and
management of
FM by searching
PubMed
references from
articles and
selected papers
based on quality,
relevant to the
potential for
future
improvement,
importance in
illustrating
current
management
pathways, and
relevance to the
illness.

The
implementation
of a framework
for chronic pain
management in
primary care
would limit
unnecessary,
time‐consuming,
and costly tests,
reduce
diagnostic delay
and improve
patient outcome
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A peer-reviewed
journal supports
the conclusions
that FM is
significant in
presenting
current
management
pathways and
strategies
necessary for
future
improvements.

Providing a
patient-centered
medical home
for managing
FM patients
would allow
these patients to
be successfully
managed in
primary care
clinics. Primary
care clinics
manage many
other chronically
diagnosed
patients, and
several barriers
have to be
overcome before
this can be
implemented.

Fitzcharles, M.,
Perrot, S., &
Häuser, W.
(2018).Comorb
id
fibromyalgia:
A Qualitative
review of
prevalence and
Importance.
European
Journal of
Pain, 2(9),
15651576.https://doi
.org/1.1002/ejp
.1252

829 previously
diagnosed FM
patients and
controls using
rheumatologist
physical and
interview
examinations,
including a
widespread
pain index
(WPI) and
symptom
severity (SS),
measure the
number of
painful body
regions and the
severity of
symptoms.

Pastor, M. A.,
NA
López-Roig, S.,
Johnston, M.,
Gracia, R., &
Daza, P.
(2012).Clinical
self-efficacy and
illness beliefs in
ambiguous
chronic pain
conditions:
General
Practitioners’ma
nagement of
Fibromyalgia.An
ales de
Psicología,
28(2).
https://doi.org/1

Physicians
were recruited
randomly from
a list of 113
rheumatologist
s members of
the ACR and
indicated an
interest in
participating in
the study after
an e-mail
solicitation.

A case
deﬁnition and
diagnostic
criteria for FM
have been
developed.
This simple
case definition
of FM is
correctly
diagnosed by
using the WPI
and SS scales.
Classiﬁed
88.1% of cases
classiﬁed by
the ACR
classiﬁcation
criteria and did
not require the
tender point
examination or
physical
examination.

Recommend
that a Followup study in the
primary care
setting be
completed. The
SS scale
enables the
assessment of
FM symptom
severity in
persons with
FM and those
with whom the
criteria have
not been
applied, and it
will be
instrumental in
the
longitudinal
evaluation of
patients with
various marked
symptoms.

208 General
Practitioners
recruited
voluntarily
while attending
educational
workshops on
Fibromyalgia,
completed an
adapted version
of the Brief
Illness
Perception
Questionnaire
and ad hoc
scales of clinical
self-efficacy,
clinical
behavior, and

Doctors see
Fibromyalgia as
a severe
condition and
they perceived
low control and
moderate
clinical selfefficacy. The
main causes of
Fibromyalgia
were seen to be
psychological.

GPs selfefficacy and
control
perception of
Fibromyalgia
need to be
enhanced. While
FM continues to
be an ambiguous
condition,
variations in
clinicians´
cognitions will
be important for
the care patients
receive.
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0.
018/analesps.28.
2135291
Wolfe, F.,
Clauw, D. J.,
Fitzcharles, M.,
Goldenberg, D.
L., Katz, R. S.,
Mease, P.,
Russell, A. S.,
Russell, I. J.,
Winfield, J. B.,
& Yunus, M. B.
(2010). The
American
College of
rheumatology
Preliminary
diagnostic
criteria for
fibromyalgia
and
measurement of
symptom
severity.
Arthritis Care
& Research,
62(5), 600-610.
https://doi.org/1
0.1002/acr.2014
0

satisfaction.

839 previously
diagnosed FM
patients and
controls using
rheumatologist
physical and
interview
examinations,
including a
widespread pain
index (WPI) and
symptom
severity (SS),
measure the
number of
painful body
regions and the
severity of
symptoms.

Physicians were
recruited
randomly from a
list of 113
rheumatologists
members
of the ACR and
indicated an
interest in
participating in
the study after
an e-mail
solicitation.
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A case definition
and diagnostic
criteria for FM
have been
developed. This
simple
case definition
of FM is
correctly
diagnosed by
using the WPI
and SS scales.
Classified 88.1%
of cases
classified by the
ACR
classification
criteria and did
not
require the
tender point
examination or
physical
examination.

Recommend that
a Follow-up
study in the
primary care
setting be
performed The
SS scale enables
the assessment
of FM symptom
severity in
persons with FM
and those with
whom the
criteria have not
been applied. It
will be
instrumental in
the longitudinal
evaluation of
patients with
various marked
symptoms.

Wierwille, L.
(2011).Fibromya
lgia: Diagnosing
and managing a
Complex
syndrome.
Journal of the
American
Academy of
Nurse
Practitioners,
24(4), 184-192.
https://doi.org/1
0. 111/j.17457599.
011.00671.x

Cohort
studies were
performed
using the
NewcastleOttawa Scale
(NOS)16 and
the crosssectional
studies using
Quadas

The search
included
Evidence-Based
Medicine
Reviews, Ovid
MEDLINE,
PubMed, and
CINAHL.
Search terms
used:
fibromyalgia
diagnosis,
fibromyalgia
pathophysiology
, incidence of
fibromyalgia,
fibromyalgia
comorbidities,
fibromyalgia,
etiology
fibromyalgia
treatment,
American
College of
Rheumatology
criteria. Search
limited to
sources from
1990 to 2010.
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The search
included reviews
of evidencebased medicine
limited to
sources from
1990 to 2010.
Search terms
used: FM
diagnosis, FM
pathophysiology
, FM treatment.

Treatment is
most beneficial
when tailored to
individual
patient
presentation, and
further research
is warranted,
particularly in
the domains of
pathophysiology
and efficacy of
treatment
options.

Langhorst, J.,
Musial, F.,
Klose, P., &
Hauser, W.
(2009). Efficacy
of hydrotherapy
in fibromyalgia
syndrome--a
meta-analysis of
randomized
controlled
clinical
trials. Rheumato
logy, 48(9),
1155-1159.
doi:10.1093/rhe
umatology/kep1
82

Randomized
controlled trials
(RCTs) that
compared
hydrotherapy
without exercise
with any other
intervention or
no intervention
in patients
diagnosed with
fibromyalgia
syndrome based
upon recognized
criteria were
eligible for
inclusion.

Two reviewers
independently
extracted data to
calculate
standardized
mean differences
(SMDs), using
means and
standard
deviation of
change scores
for each
intervention, and
95% confidence
intervals (CI).

To assess the
efficacy of
hydrotherapy in
fibromyalgia
syndrome
(FMS).
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This review
concluded that
there was
moderate
evidence that
hydrotherapy
had short-term
beneficial effects
on pain and
health-related
quality of life in
fibromyalgia
syndrome
patients.

The authors
stated that highquality studies
with larger
sample sizes
were required to
confirm the
conclusions of
this review.

APPENDIX E – ACR Preliminary Diagnostic Criteria for Fibromyalgia
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(Wolfe et al., 2010).
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